World Health Organization Deeply Regrets United States Formal Notification of Withdrawal and Defends Record on Global Public Health

The World Health Organization (WHO) has officially expressed profound regret following the formal notification by the United States government regarding its intention to withdraw from the global health body. As a founding member state that helped draft the WHO Constitution in 1948, the United States has historically played an indispensable role in financing, shaping, and executing international public health initiatives. The decision to sever ties marks a historic turning point in multilateral health cooperation, carrying profound implications for global disease surveillance, pandemic preparedness, and the eradication of persistent pathogens.

The notification of withdrawal has triggered a formal procedural review within the organization. These institutional implications will be rigorously evaluated by the WHO Executive Board during its upcoming regular meeting scheduled to begin on February 2, followed by broader deliberations at the annual World Health Assembly in May 2026. While the legal and financial mechanisms of withdrawal will take time to fully materialize, health policy experts around the globe have already begun weighing the geopolitical and epidemiological fallout of a U.S. departure from the Geneva-based agency.

A Legacy of Joint Public Health Triumphs

To understand the weight of the current diplomatic rupture, observers must look back at more than seven decades of collaborative achievements between Washington and the WHO. American financial backing, scientific expertise, and logistical leadership have been foundational to nearly every major public health victory coordinated by the United Nations specialized agency.

Most notably, the global eradication of smallpox—officially declared in 1980—was spearheaded by a coalition that heavily relied on U.S. funding, public health personnel, and the deployment of the American-manufactured bifurcated needle and vaccine supply chains. Beyond smallpox, the United States has been a primary financial and technical engine behind historic campaigns to eliminate polio, control HIV/AIDS through transformative initiatives like PEPFAR, and roll back the devastating impacts of tuberculosis, malaria, Ebola, and influenza. American contributions have similarly fortified global frameworks governing antimicrobial resistance, food safety standards, and the containment of neglected tropical diseases.

The sudden withdrawal of the world’s largest economy and historical top financial contributor threatens to leave a massive funding void and disrupt vital technical cooperation networks that protect populations across borders.

Washington’s Grievances and the U.S. Rationale

The formal notice of withdrawal submitted by the United States outlines several sharp criticisms of the WHO’s leadership, operational efficiency, and governance. Chief among the American grievances are allegations of institutional failures during the COVID-19 pandemic. Specifically, the U.S. government asserted that the WHO obstructed the timely and transparent sharing of critical epidemiological information during the initial outbreak phase and subsequently attempted to conceal those operational missteps.

Furthermore, Washington’s official statements accused the organization of pursuing a politicized, bureaucratic agenda allegedly driven by member states hostile to American interests, claiming that the WHO had "trashed and tarnished" the United States and compromised its institutional independence.

In response to these allegations, WHO leadership has mounted a robust defense, rejecting the characterization of bias or mismanagement. The organization maintains that it has consistently engaged with the United States in good faith, treating Washington with the same diplomatic respect for national sovereignty afforded to all 194 member states.

Regarding claims of politicization, the WHO emphasizes its status as an impartial technical agency governed collectively by its global membership. Operating without fear or favor, the agency insists its core mandate is strictly humanitarian and scientific, designed to serve all populations equitably irrespective of shifting geopolitical currents.

The Chronology of the COVID-19 Outbreak and WHO Response

To counter criticisms regarding its handling of the early days of the coronavirus crisis, the WHO has pointed to a detailed, publicly documented timeline of its actions, communications, and emergency alerts during the final weeks of 2019 and the opening month of 2020.

The chronology of events highlights the rapid mobilization of international health systems:

• December 31, 2019: The WHO’s Country Office in China picked up a media statement from the Wuhan Municipal Health Commission concerning cases of "viral pneumonia" of unknown etiology. Later that same day, the WHO’s Epidemic Intelligence service formally requested verification from Chinese authorities and activated its internal Incident Management System at the headquarters, regional, and country levels.
• January 1, 2020: The WHO formally requested detailed information from Chinese national authorities concerning the cluster of pneumonia cases in Wuhan to assess the risk and potential for international spread.
• January 5, 2020: The WHO published its first Disease Outbreak News report, disseminating technical guidance to all member states detailing the unknown pneumonia outbreak, outlining diagnostic recommendations, and advising standard infection prevention protocols.
• January 11, 2020: Following reports of the first recorded death from the novel virus in China, the WHO widely disseminated public warnings through formal channels, media briefings, and social media platforms, while rapidly convening global scientific networks.
• January 20-21, 2020: WHO experts conducted a brief onsite mission to Wuhan to assess the developing situation firsthand.
• January 30, 2020: Following the recommendations of the Emergency Committee convened under the International Health Regulations (IHR), the WHO Director-General declared the outbreak a Public Health Emergency of International Concern (PHEIC)—the organization’s highest legal level of alarm. At this critical juncture, fewer than 100 cases and zero deaths had been officially reported outside of China.
• February and March 2020: As transmission accelerated globally, the Director-General repeatedly warned member states that "the window of opportunity is closing," famously declaring that "this is not a drill" and labeling the pathogen "public enemy number one."

Throughout the unfolding crisis, the WHO maintained that while it issued continuous, evidence-based recommendations regarding voluntary measures such as mask-wearing, physical distancing, and vaccination, it never instituted or advocated for mandatory lockdowns, universal vaccine mandates, or coercive public health edicts. The organization stresses that its role has always been advisory, leaving sovereign governments to enact policies they deemed appropriate for their specific domestic populations.

Internal Reforms and Enhanced Global Preparedness

In the wake of multiple independent panels and after-action reviews evaluating the global response to COVID-19, the WHO has instituted a series of internal structural reforms. These adjustments are designed to streamline emergency responses, enhance transparency, and provide low- and middle-income countries with the technical capacities required to detect and suppress emerging pathogens before they escalate into pandemics.

The organization maintains that the permanent surveillance systems and rapid-response networks it operates on a continuous, round-the-clock basis serve as an essential shield for all nations, including the United States. These platforms facilitate real-time data sharing, genomic sequencing tracking, and cross-border logistical coordination that remain vital for intercepting avian influenza, Ebola flare-ups, and other high-consequence biological threats.

The Path Forward: The Pandemic Agreement and International Cooperation

Despite the diplomatic setback of the U.S. withdrawal, the broader multilateral community continues to invest heavily in strengthening international health security. A testament to this collective commitment was the historic adoption by WHO member states of the landmark WHO Pandemic Agreement. Once fully ratified under international law, this treaty aims to establish binding obligations to prevent, prepare for, and respond to future global health emergencies more equitably and efficiently.

Currently, member states are actively negotiating a vital annex to the Pandemic Agreement known as the Pathogen Access and Benefit-Sharing (PABS) system. If successfully finalized, the PABS framework will create a predictable, transparent mechanism to ensure that when a new pandemic-potential pathogen is identified, it is shared rapidly with the global scientific community, while simultaneously guaranteeing that life-saving vaccines, therapeutics, and diagnostics are distributed fairly and without delay to vulnerable populations worldwide.

Implications for Global Health Security

Public health analysts warn that the departure of the United States from the WHO could introduce significant vulnerabilities into the architecture of global health governance. Beyond the immediate budgetary shortfall—which will require burden-sharing adjustments among remaining member states—the withdrawal risks fragmenting intelligence networks and reducing the speed at which critical epidemiological data is exchanged. Pathogens do not recognize national borders, and epidemiologists stress that robust surveillance in every corner of the planet is a prerequisite for domestic health security in Washington just as much as in Geneva.

While the WHO has left the door open, expressing a clear hope that the United States will eventually reconsider and return to active participation, the agency remains resolute in its foundational mandate. Guided by its constitutional principle that the enjoyment of the highest attainable standard of health is a fundamental right of every human being, the organization continues to collaborate with its remaining 193 member states to navigate the complex health challenges of the 21st century.